Use the search parameters below to filter talks:

Calendar
Calendar

2010 - TTS International Congress (Vancouver)

Clinical Immunosuppression Kidney late
15 August 2010  /  00:00 - 00:01

Low Dose Rabbit Anti-Thymocyte Globulin in Obese Renal Transplant Patients: 8 Year Follow Up.

Presenter: Mark Reza Laftavi, Buffalo, United States

- Low Dose Rabbit Anti-Thymocyte Globulin in Obese Renal Transplant Patients: 8 Year Follow Up.

Presenter: Mark Reza Laftavi, Buffalo, United States

Low dose steroid maintenance in renal transplant recipients

Presenter: hidefumi kishikawa, nishinomiya, hyogo, Japan

- Low dose steroid maintenance in renal transplant recipients

Presenter: hidefumi kishikawa, nishinomiya, hyogo, Japan

An enteric-coated formulation of mycophenolic acid reduces the risk of suffering gastrointestinal complications regardless of dose in renal transplant patients

Presenter: Ana Sánchez-Fructuoso, Madrid, Spain

- An enteric-coated formulation of mycophenolic acid reduces the risk of suffering gastrointestinal complications regardless of dose in renal transplant patients

Presenter: Ana Sánchez-Fructuoso, Madrid, Spain

Clinical Experience with Everolimus in 122 Recipients of a Kidney or Stem Cell Transplant

Presenter: Frieder Keller, Ulm, Germany

- Clinical Experience with Everolimus in 122 Recipients of a Kidney or Stem Cell Transplant

Presenter: Frieder Keller, Ulm, Germany

Conversion from a Calcineurin Inhibitor to an Everolimus based regimen in renal transplant recipients is followed by an improvement in glucose metabolism

Presenter: Juan Ruiz, Santander, Spain

- Conversion from a Calcineurin Inhibitor to an Everolimus based regimen in renal transplant recipients is followed by an improvement in glucose metabolism

Presenter: Juan Ruiz, Santander, Spain

Excellent renal function, patient and graft survival with long-term use of once-daily prolonged-release tacrolimus in kidney transplant recipients

Presenter: Bernhard Krämer, Mannheim, Germany

- Excellent renal function, patient and graft survival with long-term use of once-daily prolonged-release tacrolimus in kidney transplant recipients

Presenter: Bernhard Krämer, Mannheim, Germany

Long-term follow-up experience with tacrolimus once-daily prolonged release in kidney, liver and heart transplant recipients

Presenter: J van Hooff, Maastricht, Netherlands

- Long-term follow-up experience with tacrolimus once-daily prolonged release in kidney, liver and heart transplant recipients

Presenter: J van Hooff, Maastricht, Netherlands

A prospective multicenter open-label randomized study to assess efficacy and safety of everolimus with ciclosporine-microemulsion (CsA-ME) versus everolimus without calcineurine inhibitor with mycophenolate sodium, in maintenance adult kidney transplant p

Presenter: Elisabeth CASSUTO, Nice, France

- A prospective multicenter open-label randomized study to assess efficacy and safety of everolimus with ciclosporine-microemulsion (CsA-ME) versus everolimus without calcineurine inhibitor with mycophenolate sodium, in maintenance adult kidney transplant p

Presenter: Elisabeth CASSUTO, Nice, France

Steroid-free immunosuppression - long term results of a prospective follow-up

Presenter: Kai Lopau, Wuerzburg, Germany

- Steroid-free immunosuppression - long term results of a prospective follow-up

Presenter: Kai Lopau, Wuerzburg, Germany

Switching from Cyclosporine to Tacrolimus : benefical effect in patients with late ac ute rejection

Presenter: Ekaterina Stolyarevich, Moscow, Russian Federation

- Switching from Cyclosporine to Tacrolimus : benefical effect in patients with late ac ute rejection

Presenter: Ekaterina Stolyarevich, Moscow, Russian Federation

The Importance of the Relationship between Patient Adherence and Drug Exposure: A Case Study Using Cyclosporine (CsA) in Kidney Transplantation

Presenter: Michael Heifets, Princeton, United States

- The Importance of the Relationship between Patient Adherence and Drug Exposure: A Case Study Using Cyclosporine (CsA) in Kidney Transplantation

Presenter: Michael Heifets, Princeton, United States

Long Term Effect of Increased Mycophenolic Acid (MPA) on Donor Specific HLA Antibody (DSA) Strength and IgG Levels in Kidney Transplant Recipients

Presenter: Paul Bolin, ,

- Long Term Effect of Increased Mycophenolic Acid (MPA) on Donor Specific HLA Antibody (DSA) Strength and IgG Levels in Kidney Transplant Recipients

Presenter: Paul Bolin, ,

The use of cyclosporin A and mycophenolate mofetil 48 hours before renal transplantation enables the use of a low dose cyclosporin and better graft function

Presenter: Hoda Mamoun, cairo, Egypt

- The use of cyclosporin A and mycophenolate mofetil 48 hours before renal transplantation enables the use of a low dose cyclosporin and better graft function

Presenter: Hoda Mamoun, cairo, Egypt

Everolimus (EVE) in maintenance renal transplant recipients converted from calcineurin inhibitors (CNI) immunosuppression treatment

Presenter: Manuel Rengel, Madrid, Spain

- Everolimus (EVE) in maintenance renal transplant recipients converted from calcineurin inhibitors (CNI) immunosuppression treatment

Presenter: Manuel Rengel, Madrid, Spain

Impact of Omeprazole on Mycophenolic Acid Pharmacokinetics in Adult Kidney Transplant Recipients

Presenter: Petrina Fan, Brisbane, Australia

- Impact of Omeprazole on Mycophenolic Acid Pharmacokinetics in Adult Kidney Transplant Recipients

Presenter: Petrina Fan, Brisbane, Australia

Trough level mycophenolic acid monitoring for toxicity is effective in optimising therapy in kidney transplant patients

Presenter: SU MEIN GOH, SINGAPORE, Singapore

- Trough level mycophenolic acid monitoring for toxicity is effective in optimising therapy in kidney transplant patients

Presenter: SU MEIN GOH, SINGAPORE, Singapore

GI adverse effects profile change in kidney transplant recipients after switching from MMF to EC-MPS

Presenter: Arkadiusz Urbanowicz, Warsaw, Poland

- GI adverse effects profile change in kidney transplant recipients after switching from MMF to EC-MPS

Presenter: Arkadiusz Urbanowicz, Warsaw, Poland

The effect of change or modulation of maintain immunosuppressive regimen on long-term transplant result

Presenter: Kyu Ha Huh, Seoul, Korea

- The effect of change or modulation of maintain immunosuppressive regimen on long-term transplant result

Presenter: Kyu Ha Huh, Seoul, Korea

Improvement of graft function and cardiovascular risk factors after once daily tacrolimus conversion in stable kidney transplant patients

Presenter: Francesca Tinti, Rome, Italy

- Improvement of graft function and cardiovascular risk factors after once daily tacrolimus conversion in stable kidney transplant patients

Presenter: Francesca Tinti, Rome, Italy

The influence of ABCB1 genotype on blood sirolimus concentrations following switch from a calcineurin inhibitor

Presenter: Iain MacPhee, London,

- The influence of ABCB1 genotype on blood sirolimus concentrations following switch from a calcineurin inhibitor

Presenter: Iain MacPhee, London,

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi